Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
38.9000 +0.3200 (+0.83%) 04/17/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 38.9000 unch (unch) 16:00 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
38.7800
Day High
39.2737
Open 39.2100
Previous Close 38.5800 38.5800
Volume 2,893,700 2,893,700
Avg Vol 2,858,385 2,858,385
Stochastic %K 53.25% 53.25%
Weighted Alpha +20.48 +20.48
5-Day Change +2.0400 (+5.53%) +2.0400 (+5.53%)
52-Week Range 29.2000 - 44.3100 29.2000 - 44.3100
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 248,101,728
  • Shares Outstanding, K 6,377,936
  • Annual Sales, $ 70,874 M
  • Annual Income, $ 9,402 M
  • EBIT $ 0 M
  • EBITDA $ 19,129 M
  • 60-Month Beta 0.48
  • Price/Sales 3.58
  • Price/Cash Flow 11.70
  • Price/Book 5.99
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/06/25
  • Annual Dividend & Yield 0.86 (2.20%)
  • Most Recent Dividend 0.856 on 03/28/25
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.7500 +11.94%
on 04/09/25
Period Open: 44.2400
44.1400 -11.87%
on 03/18/25
-5.3400 (-12.07%)
since 03/17/25
3-Month
34.7500 +11.94%
on 04/09/25
Period Open: 36.3500
44.3100 -12.21%
on 03/17/25
+2.5500 (+7.02%)
since 01/17/25
52-Week
29.2000 +33.22%
on 05/02/24
Period Open: 30.0800
44.3100 -12.21%
on 03/17/25
+8.8200 (+29.32%)
since 04/17/24

Most Recent Stories

More News
Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its danuglipron weight loss pill program. The European Commission granted marketing...

JNJ : 157.47 (+2.31%)
RHHBY : 38.9000 (+0.83%)
PFE : 22.14 (+0.45%)
SNY : 50.90 (+0.67%)
This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now?

Recursion Pharmaceuticals stock rallied as FDA announces plans of using AI for drug testing. Is it too late to invest in RXRX shares?

MRK : 78.00 (+2.01%)
RXRX : 5.50 (+3.38%)
RHHBY : 38.9000 (+0.83%)
SNY : 50.90 (+0.67%)
Should You Buy These 2 Nvidia-Backed Stocks Now?

Is Nvidia’s investment a good reason to buy these stocks?

NVDA : 101.49 (-2.87%)
APLD : 3.95 (-3.19%)
RXRX : 5.50 (+3.38%)
RHHBY : 38.9000 (+0.83%)
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

Might the tariff risk for pharmaceutical stocks be less than you think?

AZN : 67.59 (+0.81%)
LLY : 839.96 (+14.30%)
RHHBY : 38.9000 (+0.83%)
Roche's Higher Dose of Ocrevus Fails to Meet Goal in RMS Study

Swiss pharma giant Roche RHHBY faced a setback in its efforts to develop a higher dose of multiple sclerosis drug Ocrevus (ocrelizumab).The company announced that a phase III study, MUSETTE, which compared...

BAYRY : 6.0200 (+1.86%)
GILD : 104.54 (-0.32%)
REGN : 563.16 (+2.53%)
RHHBY : 38.9000 (+0.83%)
Novo Nordisk Down 15% in March: Is This a Buying Opportunity?

Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time frame,...

NVO : 58.08 (-7.63%)
LLY : 839.96 (+14.30%)
RHHBY : 38.9000 (+0.83%)
AMGN : 277.29 (-1.89%)
2 Small-Cap Stocks Set to Skyrocket With Upside Potential Between 36% and 102%

These smaller stocks may carry more risk, but they also carry greater reward potential.

NVDA : 101.49 (-2.87%)
BAYRY : 6.0200 (+1.86%)
RXRX : 5.50 (+3.38%)
ARDX : 4.82 (+4.67%)
RHHBY : 38.9000 (+0.83%)
SNY : 50.90 (+0.67%)
The Best Vanguard ETF to Invest $1,000 in Right Now

What to invest in now -- that may seem like a tough decision, given the current economic uncertainty in the U.S. including ongoing tariff-related concerns. Investors are worried about inflation, about...

SONY : 24.01 (+2.78%)
SAP : 257.40 (-1.18%)
SPGI : 462.88 (-0.24%)
NVS : 110.86 (+1.17%)
RHHBY : 38.9000 (+0.83%)
VIGI : 82.44 (+1.18%)
NSRGY : 107.7400 (+3.19%)
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of experimental RNAi therapeutics is focused across three strategic therapeutic...

ALNY : 234.56 (+1.76%)
NVS : 110.86 (+1.17%)
REGN : 563.16 (+2.53%)
RHHBY : 38.9000 (+0.83%)
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Ignore the noise in GLP-1 stocks. Find the best value instead.

VKTX : 23.94 (+1.44%)
NVO : 58.08 (-7.63%)
LLY : 839.96 (+14.30%)
RHHBY : 38.9000 (+0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its...

See More

Key Turning Points

3rd Resistance Point 39.6828
2nd Resistance Point 39.4783
1st Resistance Point 39.1891
Last Price 38.9000
1st Support Level 38.6954
2nd Support Level 38.4909
3rd Support Level 38.2017

See More

52-Week High 44.3100
Last Price 38.9000
Fibonacci 61.8% 38.5380
Fibonacci 50% 36.7550
Fibonacci 38.2% 34.9720
52-Week Low 29.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro